Accelerator Life Science Partners (ALSP), has launched the Series A financing of Automera, a new biotechnology company that focuses on the development of autophagy-targeting chimaera small molecules (AUTACs). Augmented with quantum chemistry and artificial intelligence (AI) enabled drug discovery tools, Automera’s AUTACs have the broad potential to rapidly generate novel…
